These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32253244)
21. 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. Centurión D; Glusa E; Sánchez-López A; Valdivia LF; Saxena PR; Villalón CM Eur J Pharmacol; 2004 Oct; 502(3):239-42. PubMed ID: 15476750 [TBL] [Abstract][Full Text] [Related]
22. Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists. Avdonin PV; Nadeev AD; Mironova GY; Zharkikh IL; Avdonin PP; Goncharov NV Oxid Med Cell Longev; 2019; 2019():1701478. PubMed ID: 30886671 [TBL] [Abstract][Full Text] [Related]
23. Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling. Memari B; Bouttier M; Dimitrov V; Ouellette M; Behr MA; Fritz JH; White JH J Immunol; 2015 Nov; 195(9):4479-91. PubMed ID: 26416282 [TBL] [Abstract][Full Text] [Related]
24. Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia. Lee YH; Lin CH; Hsu PC; Sun YY; Huang YJ; Zhuo JH; Wang CY; Gan YL; Hung CC; Kuan CY; Shie FS Glia; 2015 Jul; 63(7):1138-54. PubMed ID: 25690886 [TBL] [Abstract][Full Text] [Related]
25. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes. Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660 [TBL] [Abstract][Full Text] [Related]
26. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428 [TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor. Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648 [TBL] [Abstract][Full Text] [Related]
28. Transcriptomic signatures reveal a shift towards an anti-inflammatory gene expression profile but also the induction of type I and type II interferon signaling networks through aryl hydrocarbon receptor activation in murine macrophages. Schmidt JR; Haupt J; Riemschneider S; Kämpf C; Löffler D; Blumert C; Reiche K; Koehl U; Kalkhof S; Lehmann J Front Immunol; 2023; 14():1156493. PubMed ID: 37287978 [TBL] [Abstract][Full Text] [Related]
32. Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors. Kim SK; Li Y; Abrol R; Heo J; Goddard WA J Chem Inf Model; 2011 Feb; 51(2):420-33. PubMed ID: 21299232 [TBL] [Abstract][Full Text] [Related]
33. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345 [TBL] [Abstract][Full Text] [Related]
38. 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Ullmer C; Boddeke HG; Schmuck K; Lübbert H Br J Pharmacol; 1996 Mar; 117(6):1081-8. PubMed ID: 8882600 [TBL] [Abstract][Full Text] [Related]
39. Serotonin acts as a novel regulator of interleukin-6 secretion in osteocytes through the activation of the 5-HT(2B) receptor and the ERK1/2 signalling pathway. Li X; Ma Y; Wu X; Hao Z; Yin J; Shen J; Li X; Zhang P; Wang H Biochem Biophys Res Commun; 2013 Nov; 441(4):809-14. PubMed ID: 24211588 [TBL] [Abstract][Full Text] [Related]